Novartis AG (NVS) Monday said that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, related to its previously announced tender offer to acquire Regulus Therapeutics Inc. has been expired.
Expiration of the waiting period under the HSR Act is one of the conditions required for the consummation of the agreement.
As per the tender offer, Regulus will receive $7 per share, and one contingent value right per Share, representing the right to receive one contingent payment of $7 in cash.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.